Lindsay A. Rosenwald MD - 01 Jan 2023 Form 4 Insider Report for Fortress Biotech, Inc. (FBIO)

Role
President, CEO & Chairman, Director, 10%+ Owner
Signature
/s/ Samuel Berry, Attorney-in-Fact
Issuer symbol
FBIO
Transactions as of
01 Jan 2023
Net transactions value
+$3,113
Form type
4
Filing time
04 Jan 2023, 20:28:22 UTC
Previous filing
05 Dec 2022
Next filing
14 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FBIO COMMON STOCK, PAR VALUE $0.001 Award $3,113 +4,264 +0.04% $0.7300 11,734,588 01 Jun 2022 Direct F1
transaction FBIO COMMON STOCK, PAR VALUE $0.001 Award $0 +1,219,294 +10% $0.000000 12,953,882 01 Jan 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
F2 The Reporting Person was granted 1,219,294 restricted shares pursuant to the Issuer's Long-Term Incentive Plan on January 1, 2023.